Sign in
6-K

Report of Foreign Issuer

ASCENTAGE PHARMA GROUP INTERNATIONAL Filed Acc 0001213900-26-120260

INCLUSION OF LISAFTOCLAX ANNOUNCEMENT DATED NOVEMBER 16, 2026

  • SHARE PURCHASE ANNOUNCEMENT DATED NOVEMBER 16, 2026
  • CORPORATE DECK

From the SEC's structured data for this filing

Loading ea0312299-6k_ascentage.htm…